{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:20:45Z","timestamp":1784042445070,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2003,8,29]],"date-time":"2003-08-29T00:00:00Z","timestamp":1062115200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2003,11]]},"DOI":"10.1007\/s00213-003-1540-9","type":"journal-article","created":{"date-parts":[[2003,11,20]],"date-time":"2003-11-20T17:52:58Z","timestamp":1069350778000},"page":"242-254","source":"Crossref","is-referenced-by-count":93,"title":["Characterizing the subjective, psychomotor, and physiological effects of oral oxycodone in non-drug-abusing volunteers"],"prefix":"10.1007","volume":"170","author":[{"given":"James P.","family":"Zacny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,8,29]]},"reference":[{"key":"1540_CR1","unstructured":"Aceto MD, Kipps BR, Harris LS, Bowman ER (2002) Updated studies on oxycodone, the active ingredient of the controlled-release formulation. Oxy Contin Drug Alcohol Depend 66 [Suppl 1]:S2"},{"key":"1540_CR2","unstructured":"American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders-IV. American Psychiatric Association, Washington"},{"key":"1540_CR3","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3758\/BF03331551","volume":"10","author":"Baddeley","year":"1968","unstructured":"Baddeley AD (1968) A three-minute reasoning test based on grammatical transformation. Psychonomic Sci 10:341\u2013342","journal-title":"Psychonomic Sci"},{"key":"1540_CR4","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1097\/00000542-199903000-00013","volume":"90","author":"Black","year":"1999","unstructured":"Black ML, Hill JL, Zacny JP (1999) Behavioral and physiological effects of remifentanil and alfentanil in healthy volunteers. Anesthesiology 90:718\u2013726","journal-title":"Anesthesiology"},{"key":"1540_CR5","first-page":"1528","volume":"271","author":"Cleary","year":"1994","unstructured":"Cleary J, Mikus G, Somogyi A, Bochner F (1994) The influence of pharmacogenetics on opioid analgesia: studies with codeine and oxycodone in the Sprague-Dawley dark agouti rat model. J Pharmacol Exp Ther 271:1528\u20131534","journal-title":"J Pharmacol Exp Ther"},{"key":"1540_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1177\/026988118700100204","volume":"2","author":"Curran","year":"1987","unstructured":"Curran HV, Allen D, Lader M (1987) The effects of single doses of alpidem and lorazepam on memory and psychomotor performance in normal volunteers. J Psychopharmacol 2:81\u201389","journal-title":"J Psychopharmacol"},{"key":"1540_CR7","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s002280050651","volume":"55","author":"Curtis","year":"1999","unstructured":"Curtis GB, Johnson GH, Clark P, Taylor R, Brown J, O'Callaghan R, Shi M, Lacouture PG (1999) Relative potency of controlled-release oxycodone and controlled-release morphine in a postoperative pain model. Eur J Clin Pharmacol 55:425\u2013429","journal-title":"Eur J Clin Pharmacol"},{"key":"1540_CR8","unstructured":"Deneau G, Seevers MH (1957) Studies in the monkey (Macacca mulatta) designed to determine the value of this animal for predicting addiction liability to the newer synthetic analgesics. Bull Drug Addiction Narcotics, Appendix N, pp\u00a01709\u20131710"},{"key":"1540_CR9","first-page":"13","volume":"9","author":"Derogatis","year":"1973","unstructured":"Derogatis LR, Lipman RS, Cozi L (1973) HSCL-90: An outpatient psychiatric rating scale-a preliminary report. Psychopharmacol Bull 9:13\u201317","journal-title":"Psychopharmacol Bull"},{"key":"1540_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s002130050208","volume":"130","author":"Dykstra","year":"1997","unstructured":"Dykstra LA, Preston KL, Bigelow GE (1997) Discriminative stimulus and subjective effects of opioids with mu and kappa activity: data from laboratory animals and human subjects. Psychopharmacology 130:14\u201327","journal-title":"Psychopharmacology"},{"key":"1540_CR11","first-page":"381","volume":"64","author":"Falk","year":"1917","unstructured":"Falk E (1917) Eukodal, ein neues narkoticum. Muenchener Med Wochenschr 64:381\u2013384","journal-title":"Muenchener Med Wochenschr"},{"key":"1540_CR12","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1056\/NEJM198507113130205","volume":"313","author":"Foley","year":"1985","unstructured":"Foley KM (1985) The treatment of cancer pain. N Engl J Med 313:84\u201395","journal-title":"N Engl J Med"},{"key":"1540_CR13","first-page":"371","volume":"133","author":"Fraser","year":"1961","unstructured":"Fraser HF, van Horn GD, Martin WR, Wolbach AB, Isbell H (1961) Methods for evaluating addiction liability. (a) \"attitude\" of opiate addicts toward opiate-like drugs, (b) a short-term \"direct\" addiction test. J Pharmacol Exp Ther 133:371\u2013387","journal-title":"J Pharmacol Exp Ther"},{"key":"1540_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2466\/pr0.1966.18.1.163","volume":"18","author":"Haertzen","year":"1966","unstructured":"Haertzen CA (1966) Development of scales based on patterns of drug effects, using the Addiction Research Center Inventory (ARCI). Psychol Rep 18:163\u2013194","journal-title":"Psychol Rep"},{"key":"1540_CR15","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1136\/bmj.3.5715.132","volume":"3","author":"Hannington-Kiff","year":"1970","unstructured":"Hannington-Kiff JG (1970) Measurement of recovery from outpatient general anaesthesia with a simple ocular test. BMJ 3:132\u2013135","journal-title":"BMJ"},{"key":"1540_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0304-3959(97)00072-9","volume":"73","author":"Heiskanen","year":"1997","unstructured":"Heiskanen T, Kalso E (1997) Controlled-release oxycodone and morphine in cancer related pain. Pain 73:37\u201345","journal-title":"Pain"},{"key":"1540_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s002130000500","volume":"152","author":"Hill","year":"2000","unstructured":"Hill JL, Zacny JP (2000) Comparing the subjective, psychomotor, and physiological effects of intravenous hydromorphone and morphine in normal volunteers. Psychopharmacology 152:31\u201339","journal-title":"Psychopharmacology"},{"key":"1540_CR18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S0009-9236(96)90024-7","volume":"59","author":"Kaiko","year":"1996","unstructured":"Kaiko RF, Benziger DP, Fitzmartin RD, Burke BE, Reder RF, Goldenheimer PD (1996) pharmacokinetic\u2013pharmacodynamic relationships of controlled-release oxycodone. Clin Pharmacol Ther 59:52\u201361","journal-title":"Clin Pharmacol Ther"},{"key":"1540_CR19","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/clpt.1990.85","volume":"47","author":"Kalso","year":"1990","unstructured":"Kalso E, Vainio A (1990) Morphine and oxycodone hydrochloride in the management of cancer pain. Clin Pharmacol Ther 47:639\u2013646","journal-title":"Clin Pharmacol Ther"},{"key":"1540_CR20","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1056\/NEJM199610103351507","volume":"335","author":"Levy","year":"1996","unstructured":"Levy MH (1996) Pharmacological treatment of cancer pain. N Engl J Med 335:1124\u20131132","journal-title":"N Engl J Med"},{"key":"1540_CR21","unstructured":"Martin WR, Gorodetszky CW, Kay DC, McClane TK, Jasinski DR (1966) Activities of the addiction research center during 1965. Appendix 19. In: Committee on problems of drug dependence. Minutes of the 28th meeting, National Academy of Sciences, National Research Council, Washington, DC, pp\u00a04658\u20134660"},{"key":"1540_CR22","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/cpt1971122part1245","volume":"12","author":"Martin","year":"1971","unstructured":"Martin WR, Sloan JW, Sapira JD, Jasinski DR (1971) Physiologic, subjective and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 12:245\u2013258","journal-title":"Clin Pharmacol Ther"},{"key":"1540_CR23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S1082-3174(99)70044-9","volume":"8","author":"C Miaskowski","year":"1999","unstructured":"Miaskowski C, Levine JD (1999) Does opioid analgesia show a gender preference for females? Pain Forum 8:34\u201344","journal-title":"Pain Forum"},{"key":"1540_CR24","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S1090-3801(98)90020-9","volume":"2","author":"Mucci-LoRusso","year":"1998","unstructured":"Mucci-LoRusso P, Berman BS, Silberstein PT, Citron ML, Bressler L, Weinstein SM, Kaiko RF, Buckley BJ, Reder RF (1998) Controlled-release oxycodone compared with controlled-release morphine in the treatment of cancer pain: a randomized, double-blind, parallel-group study. Eur J Pain 2:239\u2013249","journal-title":"Eur J Pain"},{"key":"1540_CR25","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1600-0773.1991.tb01253.x","volume":"68","author":"Nuotto","year":"1991","unstructured":"Nuotto EJ, Korttila K (1991) Evaluation of a new computerized psychomotor test battery: effects of alcohol. Pharmacol Toxicol 68:360\u2013365","journal-title":"Pharmacol Toxicol"},{"key":"1540_CR26","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000119177","volume":"31","author":"O'Hanlon","year":"1995","unstructured":"O'Hanlon JF, Vermeeren A, Uiterwijk MMC, van Veggel LMA, Swijgman HF (1995) Anxiolytics' effects on the actual driving performance of patients and healthy volunteers in a standardized test. Neuropsychobiology 31:81\u201388","journal-title":"Neuropsychobiology"},{"key":"1540_CR27","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/BF00194333","volume":"48","author":"O'Neill","year":"1995","unstructured":"O'Neill WM, Hanks GW, White L, Simpson P, Wesnes K (1995) The cognitive and psychomotor effects of opioid analgesics. I. A randomized controlled trial of single doses of dextropropoxyphene, lorazepam and placebo in healthy subjects. Eur J Clin Pharmacol 48:447\u2013453","journal-title":"Eur J Clin Pharmacol"},{"key":"1540_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1037\/h0025327","volume":"76S","author":"Paivio","year":"1968","unstructured":"Paivio A, Yulle JC, Madigan SA (1968) Concreteness, imagery, and meaningfulness values for 925 nouns. J Exp Psychol 76S:1\u201325","journal-title":"J Exp Psychol"},{"key":"1540_CR29","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0376-8716(98)00026-X","volume":"50","author":"Petry","year":"1998","unstructured":"Petry NM, Bickel WK, Huddleston J, Tzanis E, Badger GJ (1998) A comparison of subjective, psychomotor and physiological effects of a novel muscarinic analgesic, LY297802 tartrate, and oral morphine in occasional drug users. Drug Alcohol Depend 50:129\u2013136","journal-title":"Drug Alcohol Depend"},{"key":"1540_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0885-3924(93)90101-Z","volume":"8","author":"Poyhia","year":"1993","unstructured":"Poyhia R, Vainio A, Kalso E (1993) A review of oxycodone's clinical pharmacokinetics and pharmacodynamics. J Pain Symptom Manage 8:63\u201367","journal-title":"J Pain Symptom Manage"},{"key":"1540_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0376-8716(91)90053-2","volume":"28","author":"Preston","year":"1991","unstructured":"Preston KL, Jasinski DR (1991) Abuse liability studies of opioid agonist-antagonists in humans. Drug Alcohol Depend 28:49\u201382","journal-title":"Drug Alcohol Depend"},{"key":"1540_CR32","first-page":"184","volume":"250","author":"Preston","year":"1989","unstructured":"Preston KL, Bigelow GE, Bickel WK, Liebson IA (1989) Drug discrimination in human postaddicts: agonist-antagonist opioids. J Pharmacol Exp Ther 250:184\u2013196","journal-title":"J Pharmacol Exp Ther"},{"key":"1540_CR33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0304-3959(97)00093-6","volume":"73","author":"Ross","year":"1997","unstructured":"Ross FB, Smith MT (1997) The intrinsic antinociceptive effects of oxycodone appear to be kappa-opioid receptor mediated. Pain 73:151\u2013157","journal-title":"Pain"},{"key":"1540_CR34","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1176\/ajp.127.12.1653","volume":"127","author":"Selzer","year":"1971","unstructured":"Selzer ML (1971) The Michigan alcoholism screening test: the quest for a new diagnostic instrument. Am J Psychiatry 127:89\u201394","journal-title":"Am J Psychiatry"},{"key":"1540_CR35","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/j.1365-2125.1976.tb00635.x","volume":"3","author":"Seppala","year":"1976","unstructured":"Seppala K, Korttila K, Hakkinene S, Linnoila M (1976) Residual effects and skills related to driving after a single oral administration of diazepam, medazepam or lorazepam. Br J Clin Pharmacol 3:831\u2013841","journal-title":"Br J Clin Pharmacol"},{"key":"1540_CR36","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/j.1399-6576.1998.tb05169.x","volume":"42","author":"Silvasti","year":"1998","unstructured":"Silvasti M, Rosenberg P, Seppala T, Svartling N, Pitkanen M (1998) Comparison of analgesic efficacy of oxycodone and morphine in postoperative intravenous patient-controlled analgesia. Acta Anaesthesiol Scand 42:576\u2013580","journal-title":"Acta Anaesthesiol Scand"},{"key":"1540_CR37","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/BF00615963","volume":"29","author":"Subhan","year":"1986","unstructured":"Subhan Z, Harrison C, Hindmarch I (1986) Alprazolam and lorazepam: single and multiple-dose effects on psychomotor skills and sleep. Eur J Clin Pharmacol 29:709\u2013712","journal-title":"Eur J Clin Pharmacol"},{"key":"1540_CR38","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA) (2002a) Office of Applied Studies. Results from the 2001 National Household Survey on Drug Abuse, volume II. Technical appendices and selected data tables. NHSDA Series H-18, DHHS Publication No. SMA 02\u20133759, Rockville, MD"},{"key":"1540_CR39","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA) (2002b) Office of Applied Studies. Emergency department trends from the Drug Abuse Warning Network, final estimates 1994\u20132001. DAWN Series D-21, DHHS Publication No. SMA 02\u20133635, Rockville, MD"},{"key":"1540_CR40","unstructured":"Swain HH, Fly CL, Seevers MH (1977) Evaluation of new compounds for morphine-like physical dependence in the rhesus monkey. Proceedings of the 39th Annual Scientific Meeting of the Committee on Problems of Drug Dependence, pp\u00a0614\u2013636"},{"key":"1540_CR41","unstructured":"Thorndike EL, Lorge L (1944) The teacher's word book of 30,000 words. Columbia University Press, New York"},{"key":"1540_CR42","first-page":"1454","volume":"289","author":"Walker","year":"1999","unstructured":"Walker DJ, Zacny JP (1999) Subjective, psychomotor, and physiological effects of cumulative doses of opioid mu agonists in healthy volunteers. J Pharmacol Exp Ther 289:1454\u20131464","journal-title":"J Pharmacol Exp Ther"},{"key":"1540_CR43","doi-asserted-by":"crossref","unstructured":"Wechsler D (1958) The measurement and appraisal of adult intelligence. Williams and Wilkins, Baltimore","DOI":"10.1037\/11167-000"},{"key":"1540_CR44","doi-asserted-by":"crossref","unstructured":"Wetherell A (1996) Performance tests. Environ Health Perspect 104 [Suppl 2]:247\u2013273","DOI":"10.1289\/ehp.96104s2247"},{"key":"1540_CR45","unstructured":"Woods JH, Ko MC, Winger G, France CP, Traynor JR (2003) Evaluation of new compounds for opioid activity. In: Dewey WL, Harris LS (eds) Problems of drug dependence: Proceedings of the 64th Annual Scientific Meeting, the College on Problems of Drug Dependence, Inc. National Institute on Drug Abuse Monograph Series 183. DHHS, Rockville, MD, pp\u00a0170\u2013190"},{"key":"1540_CR46","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s00213-002-1245-5","volume":"165","author":"Zacny","year":"2003","unstructured":"Zacny JP (2003) Characterizing the subjective, psychomotor, and physiological effects of a hydrocodone combination product (Hycodan) in non-drug-abusing volunteers. Psychopharmacology 165:146\u2013156","journal-title":"Psychopharmacology"},{"key":"1540_CR47","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/BF02245155","volume":"107","author":"Zacny","year":"1992","unstructured":"Zacny JP, Lichtor JL, Zaragoza JG, de Wit H (1992) Subjective and behavioral responses to intravenous fentanyl in healthy volunteers. Psychopharmacology 107:319\u2013326","journal-title":"Psychopharmacology"},{"key":"1540_CR48","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/BF02244946","volume":"111","author":"Zacny","year":"1993","unstructured":"Zacny JP, Lichtor JL, Binstock W, Coalson DW, Cutter T, Flemming DC, Glosten B (1993) Subjective, behavioral and physiological responses to intravenous meperidine in healthy volunteers. Psychopharmacology 111:306\u2013314","journal-title":"Psychopharmacology"},{"key":"1540_CR49","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0376-8716(03)00003-6","volume":"69","author":"Zacny","year":"2003","unstructured":"Zacny J, Bigelow G, Compton P, Foley K, Iguchi M, Sannerud C (2003) College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement. Drug Alcohol Depend 69:215\u2013232","journal-title":"Drug Alcohol Depend"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-003-1540-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-003-1540-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-003-1540-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-003-1540-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T16:01:11Z","timestamp":1558627271000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-003-1540-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8,29]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["1540"],"URL":"https:\/\/doi.org\/10.1007\/s00213-003-1540-9","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,8,29]]}}}